T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS
- PMID: 15140958
- PMCID: PMC415819
- DOI: 10.1128/JVI.78.11.5612-5618.2004
T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS
Erratum in
- J Virol. 2004 Jul;78(14):7861. Yang Huang-Hua [corrected to Yang Huang-Hao]
Abstract
The immunogenicity of HLA-A2-restricted T-cell epitopes in the S protein of the Severe acute respiratory syndrome coronavirus (SARS-CoV) and of human coronavirus strain 229e (HCoV-229e) was analyzed for the elicitation of a T-cell immune response in donors who had fully recovered from SARS-CoV infection. We employed online database analysis to compare the differences in the amino acid sequences of the homologous T epitopes of HCoV-229e and SARS-CoV. The identified T-cell epitope peptides were synthesized, and their binding affinities for HLA-A2 were validated and compared in the T2 cell system. The immunogenicity of all these peptides was assessed by using T cells obtained from donors who had fully recovered from SARS-CoV infection and from healthy donors with no history of SARS-CoV infection. HLA-A2 typing by indirect immunofluorescent antibody staining showed that 51.6% of SARS-CoV-infected patients were HLA-A2 positive. Online database analysis and the T2 cell binding test disclosed that the number of HLA-A2-restricted immunogenic epitopes of the S protein of SARS-CoV was decreased or even lost in comparison with the homologous sequences of the S protein of HCoV-229e. Among the peptides used in the study, the affinity of peptides from HCoV-229e (H77 and H881) and peptides from SARS-CoV (S978 and S1203) for binding to HLA-A2 was higher than that of other sequences. The gamma interferon (IFN-gamma) release Elispot assay revealed that only SARS-CoV-specific peptides S1203 and S978 induced a high frequency of IFN-gamma-secreting T-cell response in HLA-A2(+) donors who had fully recovered from SARS-CoV infection; such a T-cell epitope-specific response was not observed in HLA-A2(+) healthy donors or in HLA-A2(-) donors who had been infected with SARS-CoV after full recovery. Thus, T-cell epitopes S1203 and S978 are immunogenic and elicit an overt specific T-cell response in HLA-A2(+) SARS-CoV-infected patients.
Figures
![FIG. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/415819/bin/zjv0110446620001.gif)
![FIG. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/415819/bin/zjv0110446620002.gif)
![FIG. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/415819/bin/zjv0110446620003.gif)
Similar articles
-
CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.Vaccine. 2010 Sep 24;28(41):6666-74. doi: 10.1016/j.vaccine.2010.08.013. Epub 2010 Aug 13. Vaccine. 2010. PMID: 20709007 Free PMC article.
-
HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.Biochem Biophys Res Commun. 2006 May 26;344(1):63-71. doi: 10.1016/j.bbrc.2006.03.152. Biochem Biophys Res Commun. 2006. PMID: 16630549 Free PMC article.
-
Immunological responses against SARS-coronavirus infection in humans.Cell Mol Immunol. 2004 Apr;1(2):119-22. Cell Mol Immunol. 2004. PMID: 16212898 Review.
-
SARS vaccine development.Emerg Infect Dis. 2005 Jul;11(7):1016-20. doi: 10.3201/1107.050219. Emerg Infect Dis. 2005. PMID: 16022774 Free PMC article. Review.
-
Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.Blood. 2004 Jul 1;104(1):200-6. doi: 10.1182/blood-2003-11-4072. Epub 2004 Mar 11. Blood. 2004. PMID: 15016646 Free PMC article.
Cited by
-
Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery.PLoS One. 2023 Oct 5;18(10):e0292156. doi: 10.1371/journal.pone.0292156. eCollection 2023. PLoS One. 2023. PMID: 37796941 Free PMC article.
-
Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants.Front Immunol. 2022 Jul 28;13:931372. doi: 10.3389/fimmu.2022.931372. eCollection 2022. Front Immunol. 2022. PMID: 35967415 Free PMC article.
-
Nanoparticles for Coronavirus Control.Nanomaterials (Basel). 2022 May 9;12(9):1602. doi: 10.3390/nano12091602. Nanomaterials (Basel). 2022. PMID: 35564311 Free PMC article. Review.
-
Computer-Based Immunoinformatic Analysis to Predict Candidate T-Cell Epitopes for SARS-CoV-2 Vaccine Design.Front Immunol. 2022 Mar 30;13:847617. doi: 10.3389/fimmu.2022.847617. eCollection 2022. Front Immunol. 2022. PMID: 35432316 Free PMC article.
-
Peptides for Vaccine Development.ACS Appl Bio Mater. 2022 Mar 21;5(3):905-944. doi: 10.1021/acsabm.1c01238. Epub 2022 Feb 23. ACS Appl Bio Mater. 2022. PMID: 35195008 Free PMC article. Review.
References
-
- Bartulewic, D., A. Markowska, S. Wolczynski, M. Dabrowska, and A. Rozanski. 2000. Molecular modelling, synthesis and antitumour activity of carbocyclic analogues of netropsin and distamycin-new carriers of alkylating elements. Acta Biochim. Pol. 47:23-35. - PubMed
-
- Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (London) 345:449-452. - PubMed
-
- Gnjatic, S., D. Atanackovic, M. Matsuo, E. Jager, S. Y. Lee, D. Valmori, Y. T. Chen, G., Ritter, A. Knuth, and L. J. Old. 2003. Cross-presentation of HLA class I epitopes from exogenous N. Y.-ESO-1 polypeptides by nonprofessional APCs. J. Immunol. 170:1191-1196. - PubMed
-
- Gricks, C. S., E. Rawlings, L. Foroni, J. A. Madrigal, and P. L. Amlot. 2001. Somatically mutated regions of immunoglobulin on human b-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Res. 61:5145-5152. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous